Works matching AU Brinton, Roberta Diaz
Results: 166
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Sex-Related Differences in Brain Volumes and Cerebral Blood Flow Among Overweight and Obese Adults With Type 2 Diabetes: Exploratory Analyses From the Action for Health in Diabetes Brain Magnetic Resonance Imaging Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease–related cognitive decline.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025, v. 11, n. 1, p. 1, doi. 10.1002/trc2.70074
- By:
- Publication type:
- Article
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
- Published in:
- Frontiers in Cellular Neuroscience, 2014, p. 1, doi. 10.3389/fncel.2014.00203
- By:
- Publication type:
- Article
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.
- Published in:
- Frontiers in Dementia, 2023, p. 1, doi. 10.3389/frdem.2023.1303256
- By:
- Publication type:
- Article
Association between CNS-active drugs and risk of Alzheimer’s and age-related neurodegenerative diseases.
- Published in:
- Frontiers in Psychiatry, 2024, p. 1, doi. 10.3389/fpsyt.2024.1358568
- By:
- Publication type:
- Article
Effects of Estrogen Plus Progestin on Risk of Dementia.
- Published in:
- 2003
- By:
- Publication type:
- Letter
Weight trajectories in aging humanized APOE mice with translational validity to human Alzheimer's risk population: A retrospective analysis.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0314097
- By:
- Publication type:
- Article
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0317303
- By:
- Publication type:
- Article
Combination therapies targeting AD risk factors delay cognitive decline over 10 years in Alzheimer's patient.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S7, p. 1, doi. 10.1002/alz.093134
- By:
- Publication type:
- Article
Impact of humanized APOE on brain volumetrics and white matter microstructure within a mouse model for Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092751
- By:
- Publication type:
- Article
Endocrinological aging drives alterations in white matter architecture: Evidence from a humanized APOE risk model of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092658
- By:
- Publication type:
- Article
Extended Exposure to Alzheimer's Risk Factors Increases Alzheimer's Diagnosis Risk Amplified in APOε4 Carriers: Implication for Delayed Onset of Alzheimer's Risk Factors.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.091806
- By:
- Publication type:
- Article
Midlife Neuroinflammatory Dynamics: The Emergence of Alzheimer's Disease Neuroimmune Profile in the Female Human Brain.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.093151
- By:
- Publication type:
- Article
APOEε4 Allele Modulates Region‐Specific Transcriptomic Changes in Epigenetic Control Pathways: Implications for Late‐Onset Alzheimer's Disease Risk.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.092722
- By:
- Publication type:
- Article
CNS‐active drugs for neuropsychiatric disorders differentially modulate the risk of AD development.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.091759
- By:
- Publication type:
- Article
Behavioral and metabolic profiles in an aged, humanized APP/APOE mouse model of Alzheimer's Disease risk.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.091716
- By:
- Publication type:
- Article
Key role of ERβ in estrogenic regulation of neuronal mitochondrial function.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.086633
- By:
- Publication type:
- Article
Sex and APOE differences in Alzheimer's Disease‐On‐Ramp risk factor profiles: Are all risk factors for Alzheimer's Disease created equal?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082316
- By:
- Publication type:
- Article
Computational identification of precision therapeutics for Alzheimer's disease specific to endocrine and APOE genotype status.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080506
- By:
- Publication type:
- Article
Development of a selective estrogen β‐receptor phytoestrogen formulation – PhytoSERM – for the reduction of Alzheimer's risk and relief of menopausal symptoms in women: a phase 2 randomized clinical trial framework.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080295
- By:
- Publication type:
- Article
The Antidepressant Therapy Selective Norepinephrine Reuptake Inhibitors (SNRIs) Reduces the Risk of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080047
- By:
- Publication type:
- Article
Sex differences in white matter bundle properties across menopausal transition states.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079940
- By:
- Publication type:
- Article
Correlational analysis of plasma metabolome and brain imaging in a humanized APOE mouse model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080468
- By:
- Publication type:
- Article
Distinct immune signatures associated with sex and genotype in the 15m novel hAPP+hAPOE mouse risk model of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080139
- By:
- Publication type:
- Article
Plasma metabolomic profiles of aged, humanized APOE mice and behavioral correlates.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080101
- By:
- Publication type:
- Article
Statin therapy reduces the risk of AD: Clinic to bench translation for protective mechanism.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080504
- By:
- Publication type:
- Article
Distinct immune signatures associated with sex and genotype in the 12m novel hAPP hAPOE mouse risk model of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080058
- By:
- Publication type:
- Article
Loss of Fatty Acid Degradation by Astrocytic Mitochondria as a Mechanism of Neuroinflammation and Neurodegeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076572
- By:
- Publication type:
- Article
Statin responder analysis for precision prevention of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.068305
- By:
- Publication type:
- Article
In‐season docosahexaenoic acid supplementation does not prevent white matter damage during a single American football season: Implications for neurodegeneration prevention.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.065751
- By:
- Publication type:
- Article
Allopregnanolone as a Regenerative Therapeutic for Alzheimer's Disease: Phase 2 proof‐of‐concept clinical trial using hippocampal volume as a surrogate endpoint.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.068251
- By:
- Publication type:
- Article
Translational potential of JAX humanized APOE mice: trajectories of resilient versus susceptible aging by sex and weight.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068242
- By:
- Publication type:
- Article
Translational potential of JAX humanized APOE mice: Hippocampal volume decline in very old mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068141
- By:
- Publication type:
- Article
Translational potential of JAX humanized APOE mice: Metabolism and body composition in very old mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068128
- By:
- Publication type:
- Article
Translational potential of JAX humanized APOE mice: Peripheral biomarkers of pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.067815
- By:
- Publication type:
- Article
Translational potential of JAX humanized APOE mice: Peripheral interferon gamma induces systemic immuno‐metabolic dysfunction.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.068655
- By:
- Publication type:
- Article
Translational potential of JAX humanized‐APOE mice: Building the foundation for translational validity by applying human clinical trial principles.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.068036
- By:
- Publication type:
- Article
Translational potential of JAX humanized‐APOE mice model: Accelerated midlife endocrine aging in hAPOEε4/4 females.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.067969
- By:
- Publication type:
- Article
Neuroinflammatory profiles of the human female brain in midlife resembles the human male late‐life Alzheimer's brain.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.068134
- By:
- Publication type:
- Article
Translational potential of JAX humanized‐APOE mice: sex differences in bioenergetic function in brain.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.068224
- By:
- Publication type:
- Article
Reduction of risk of development of Alzheimer's disease and related dementias in patients with type 2 diabetes by drugs to treat hyperglycemia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055666
- By:
- Publication type:
- Article
Statin therapies reduce risk of Alzheimer's disease and dementia with increased protective therapeutic effect with increasing age.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055735
- By:
- Publication type:
- Article
Individual classes of prostate cancer therapies impact risk of Alzheimer's disease: A claims‐based retrospective study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055615
- By:
- Publication type:
- Article
Alzheimer's disease prevention: Within reach by 2025.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055621
- By:
- Publication type:
- Article
Breast cancer therapies reduce risk of Alzheimer's disease and dementia: A claims‐based retrospective study with clinic to bench implications.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055602
- By:
- Publication type:
- Article
Differences in white matter integrity and hippocampal volumetrics across APOE genotype mice: A blinded preliminary study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054419
- By:
- Publication type:
- Article
APOE4 genetic burden and female sex impact immune profile in brain and periphery in aged mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056541
- By:
- Publication type:
- Article
Allopregnanolone potentiates bioenergetic capacity and mitochondrial biogenesis in astrocytes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056456
- By:
- Publication type:
- Article
Estrogen transcriptomic regulation of brain bioenergetics and metabolism is cell‐type‐specific and estrogen‐receptor‐subtype‐dependent.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.055545
- By:
- Publication type:
- Article